Symtomax
PrivateCompany Overview
Symtomax is a pharmaceutical and agricultural company that specializes in the cultivation, production, and distribution of medical-grade cannabis oil and cannabinoid-based products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symtomax Comparables
Compare Symtomax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AceCann | 90% | |
| GreenBE Pharma | 89% | |
| Linneo Health | 87% |
Symtomax Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2026
Monthly visitors increased 57% MoM.
Symtomax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Symtomax's valuation, stock price, and market status.
Is Symtomax a public or private company?
Symtomax is a private company.
What is the current stock price of Symtomax?
Symtomax is a private company with no public stock price. No recent secondary market data is available.
How much is Symtomax worth (valuation)?
Valuation information for Symtomax is not publicly available.
Can I buy Symtomax stock?
Symtomax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Symtomax's last funding round?
Funding round information for Symtomax is not publicly available.
Who are the main investors in Symtomax?
Investor information for Symtomax is not publicly disclosed.
Will Symtomax IPO soon?
No public IPO plans have been announced for Symtomax.
How can I track Symtomax secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Symtomax's secondary market activity and sign up for updates.